morphiceptin, n-me-phe(3)- has been researched along with vasoactive intestinal peptide in 1 studies
Studies (morphiceptin, n-me-phe(3)-) | Trials (morphiceptin, n-me-phe(3)-) | Recent Studies (post-2010) (morphiceptin, n-me-phe(3)-) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
---|---|---|---|---|---|
95 | 1 | 1 | 10,873 | 123 | 1,221 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christinck, F; Cipris, S; Daniel, EE; Fox-Threlkeld, JE; Hruby, VJ; Woskowska, Z | 1 |
1 other study(ies) available for morphiceptin, n-me-phe(3)- and vasoactive intestinal peptide
Article | Year |
---|---|
Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine.
Topics: Amino Acid Sequence; Animals; Dogs; Endorphins; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Female; Ileum; In Vitro Techniques; Male; Molecular Sequence Data; Muscle Contraction; Nitric Oxide; Peptide Fragments; Peptides; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin; Vasoactive Intestinal Peptide | 1994 |